faropenem + potassium clavulanate

Faropenem + potassium clavulanate is an oral combination antibiotic consisting of faropenem, a penem-class beta-lactam, and potassium clavulanate, a beta-lactamase inhibitor. Faropenem exerts its antibacterial effect by binding to bacterial penicillin-binding proteins (PBPs), which inhibits the synthesis of the bacterial cell wall, leading to cell death. It is active against a broad spectrum of both gram-positive and gram-negative bacteria. Potassium clavulanate is included to inhibit beta-lactamase enzymes produced by resistant bacteria, thereby protecting faropenem from enzymatic degradation and extending its antibacterial spectrum. This combination is primarily used for the treatment of various bacterial infections, including those of the respiratory tract, urinary tract, skin, bone, and gynecological infections. In India, this generic combination is distributed and marketed by companies such as Gemed Lifesciences.

Other names

faropenem + potassium clavulanatefaropenem sodium + potassium clavulanatefaropenem and clavulanic acid